ASF1B promotes erythropoiesis by regulating the establishment and dynamics of H3.3 nucleosomes

X Xiang Guo J Jinlei Liu (1Department of Hematology, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610072, China., Chengdu, China) X Xuemei Song L Lecong Zhou (2Laboratory of Cellular and Developmental Biology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA, Bethesda, United States) Y Yangu Zhao (2Laboratory of Cellular and Developmental Biology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA, Bethesda, United States) J Juhyun Kim Y Yafan Wang (3Chengdu Institute of Biology, Chinese Academy of Sciences, Chengdu 610213, China, Chengdu, China) J Jun Li A Ann Dean (2Laboratory of Cellular and Developmental Biology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA, Bethesda, United States)

Abstract

Abstract ASF1B, a histone chaperon, was synergistically expressed together with the H3f3a gene encoding the histone variant H3.3 during erythropoiesis. However, the mechanism underlying this coordination is still unclear. We found that ASF1B is a key regulator of erythrocyte development by influencing embryonic/fetal globin and H3f3a gene in erythroid progenitor cells. Moreover, the regulation of H3f3a by ASF1B was predominant over its family member ASF1A and H3.3-specific chaperone HIRA. ASF1B occupied more than 70% of H3.3 nucleosomes at erythroid gene promoters and enhancers. ASF1B suppressed the expression of embryonic/fetal globin genes in normal and disease condition by altering H3.3 enrichment and chromatin accessibility. Strikingly, the regulatory pathway of ASF1B in H3.3 deposition involved the recruitment of chromatin remodeler BRG1 and accumulation of H3K27ac in active chromatin. In summary, ASF1B plays a crucial role in H3.3 enrichment and globin gene expression that highlights the therapeutic potential of ASF1B in targeting β-globin hemoglobinopathies.

Article Details

Journal Blood
Volume / Issue Vol. 146, Issue Supplement 1
Published November 03, 2025
Pages 2884-2884
ISSN 0006-4971
Publisher Elsevier BV

Journal Info

Blood

Elsevier BV

ISSN: 0006-4971 Health Sciences

Authors (9)

X

Xiang Guo

J

Jinlei Liu

1Department of Hematology, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610072, China., Chengdu, China

X

Xuemei Song

L

Lecong Zhou

2Laboratory of Cellular and Developmental Biology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA, Bethesda, United States

Y

Yangu Zhao

2Laboratory of Cellular and Developmental Biology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA, Bethesda, United States

J

Juhyun Kim

Y

Yafan Wang

3Chengdu Institute of Biology, Chinese Academy of Sciences, Chengdu 610213, China, Chengdu, China

J

Jun Li

A

Ann Dean

2Laboratory of Cellular and Developmental Biology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA, Bethesda, United States